Page 207 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Non-Invasive Markers of Liver Fibrosis

P0507 EFFECTS OF VITAMIN D SUPPLEMENTATION ON LIVER
STIFFNESS IN PATIENTS WITH CHRONIC LIVER DISEASES
Anna König, Caroline S. Stokes, Marcin Krawczyk, Frank Lammert,
Frank Grünhage*, Germany

P0508 BIOPSY FINDINGS, ACE LEVELS AND APRI ARE SIMILAR
IN PATIENTS WITH SARCOIDOSIS WITH AND WITHOUT
PORTAL HYPERTENSION
Binu John*, Sajan Nagpal, Thomas Plesec, Ramprasad Jegadeesan,
Rocio Lopez, Naim Alkhouri, Kristin Highland, Daniel Culver,
The United States

P0509 DIAGNOSTIC AND PROGNOSTIC STAGINGS ARE
IMPROVED BY MULTI-TARGETING BIOMARKERS.
APPLICATION TO LIVER FIBROSIS TESTS
Paul Cales*, Sandrine Bertrais, Jérôme Boursier, Frédéric Oberti,
Valérie Moal, Isabelle Fouchard Hubert, Gilles Hunault,
Marie Christine Rousselet, France

P0510 DIRECT COMPARISONS OF FIBROTEST, APRI, FIB-4, AND ePOSTERS
TRANSIENT ELASTOGRAPHY (TE) FOR THE DIAGNOSIS OF
CIRRHOSIS AND FIBROSIS, IN PATIENTS WITH CHRONIC
HEPATITIS C (CHC) AND B (CHB) USING INTENTION TO
DIAGNOSE AND BAYESIAN METHODS. A SYSTEMATIC
REVIEW
Marion Houot,Yen Ngo, Mona Munteanu, Sebastien Marque,
Thierry Poynard*, France

P0511 DIRECT COMPARISON OF 3 ELASTROMETRY DEVICES
(FIBROSCAN, ACOUSTIC RADIATION FORCE IMPULSE,
SUPERSONIC SHEARWAVE IMAGING) FOR THE NON-
INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN CHRONIC
LIVER DISEASES
Jerome Boursier*, Victoire Cartier, Jerome Lebigot, Frederic Oberti,
Isabelle Fouchard-Hubert, Sandrine Bertrais, Paul Cales,
Christophe Aube, France

Vienna, Austria • April 22–26, 2015 207